Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: A role for NK cells and M1 macrophages.
Chemokine receptor expression by inflammatory T cells in EAE.
ALCAM and CD6 - multiple sclerosis risk factors.
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
Functional ionotropic glutamate receptors on peripheral axons and myelin.
Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
Neuromyelitis optica: a positive appraisal of seronegative cases.
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes.
Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
The Evi5 family in cellular physiology and pathology.
The protein arginine deiminases: Structure, function, inhibition, and disease.
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
Physical activity and depression in middle and older-aged adults with multiple sclerosis.
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis.
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Sunlight exposure and multiple sclerosis in a tropical country.
Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
Pages
« first
‹ previous
…
553
554
555
556
557
558
559
560
561
…
next ›
last »